Nanotechnology Now

Our NanoNews Digest Sponsors


Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Izon Science to sponsor Sydney 2010 International Nanomedicine Conference

Abstract:
New Zealand based nanotechnology company Izon Science, today announced its sponsorship and participation in the Sydney 2010 International Nanomedicine Conference. The three day nanomedicine conference, to be held 30 June to 2 July, will bring together researchers and developers from around the world working in targeted delivery, diagnostics and regenerative medicine.

Izon Science to sponsor Sydney 2010 International Nanomedicine Conference

New Zealand | Posted on June 29th, 2010

"We're delighted to be a sponsor. Nanomedicine is an extremely exciting and important field. It has the potential to enable early detection and prevention, and to dramatically improve diagnosis, treatment and follow-up of diseases. By collaborating with researchers through forums like this we can continue to develop world leading technology that will help break new ground in healthcare", says Hans van der Voorn, the Executive Chairman of Izon.

Izon's qNano and qViro instruments combined with the newly launched Variable Pressure Module (VPM) provide the world's most comprehensive nanoparticle analysis system.

As part of the sponsorship package Izon is donating a major prize for a fundraising event at the conference to benefit the Children's Cancer Institute Australia. The prize package includes the use of a qNano for one year, with consumables, along with full training in New Zealand and support by Izon technical staff and the travel package to New Zealand.

Researchers using Izon's nanoparticle analysis system can measure and characterize virtually all particles including nanoparticles, viruses, bacteria and bioparticles such as exosomes and liposomes. Particle concentration, electrophoretic mobility, size and aggregation kinetics can all be analysed. Real time reaction monitoring allows users to design and test nanoparticle systems by analyzing the changes in particle properties as various modifications are applied. This is useful for bio-nano work, drug delivery research or development of diagnostic applications.

Izon's instruments are used across a wide range of scientific fields including nanomedicine, bionanotechnology, virology, vaccinology, microbiology, gene therapy, medical research, marine science, aquaculture, chemistry and nanoscience. Current projects include virus quantitation and analysis, oncolytic viruses, marine science, drug delivery systems, nanoparticle charge measurement, diagnostic applications using antibodies and nanoparticles, bioparticle analysis, and controlled dispensing of particles and biomolecules by count.

The Sydney 2010 International Nanomedicine Conference will be held at the Crowne Plaza Coogee Beach in Sydney. Izon Chairman Hans van der Voorn will deliver a brief presentation at the conference dinner on Friday 2 July.

####

About Izon Science
Izon provides the world's most comprehensive nanoparticle analysis system in a single instrument. Izon is a nanotechnology company focused on measurement, analysis and single particle control. Since commencement in early 2005, Izon has developed the science, hardware and software to fabricate and control dynamically resizable nanopores. These are a practical and cost effective means for the detection, characterisation and control of nanoparticles down to the molecular scale.

For more information, please click here

Contacts:
Hans van der Voorn
Executive Chairman, Izon Science
Phone: + 64 21 463 399


Sandra Lukey
Shine Group (Media for Izon Science)
Phone: + 64 21 2262 858

Copyright © Izon Science

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Personal cooling units on the horizon April 29th, 2016

Exploring phosphorene, a promising new material April 29th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

The Translational Research Center at the University Hospital of Erlangen in Germany uses the ZetaView from Particle Metrix to quantify extracellular vesicles such as exosomes April 28th, 2016

Nanomedicine

Nanoparticles hold promise as double-edged sword against genital herpes April 28th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

The Translational Research Center at the University Hospital of Erlangen in Germany uses the ZetaView from Particle Metrix to quantify extracellular vesicles such as exosomes April 28th, 2016

JPK reports on the use of a NanoWizard AFM system at the University of Kaiserslautern to study the interaction of bacteria with microstructured surfaces April 28th, 2016

Announcements

Personal cooling units on the horizon April 29th, 2016

Exploring phosphorene, a promising new material April 29th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

The Translational Research Center at the University Hospital of Erlangen in Germany uses the ZetaView from Particle Metrix to quantify extracellular vesicles such as exosomes April 28th, 2016

Events/Classes

Researchers create a first frequency comb of time-bin entangled qubits: Discovery is a significant step toward multi-channel quantum communication and higher capacity quantum computers April 28th, 2016

Introducing the RE標ORK Bio-inspired Robotics Summit in Berlin April 27th, 2016

ORIG3N Added to Companies Presenting at Harris & Harris Group's Annual Meeting, Tuesday June 7, 2016, the New York Genome Center April 27th, 2016

Team builds first quantum cascade laser on silicon: Eliminates the need for an external light source for mid-infrared silicon photonic devices or photonic circuits April 21st, 2016

Nanobiotechnology

Nanoparticles hold promise as double-edged sword against genital herpes April 28th, 2016

Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521 April 28th, 2016

The Translational Research Center at the University Hospital of Erlangen in Germany uses the ZetaView from Particle Metrix to quantify extracellular vesicles such as exosomes April 28th, 2016

JPK reports on the use of a NanoWizard AFM system at the University of Kaiserslautern to study the interaction of bacteria with microstructured surfaces April 28th, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic